Philip Comp to Warfarin
                            
                            
                                This is a "connection" page, showing publications Philip Comp has written about Warfarin.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.788
         
        
        
     
 
    
        
        - 
            A comparison of danaparoid and warfarin for prophylaxis against deep vein thrombosis after total hip replacement: The Danaparoid Hip Arthroplasty Investigators Group. Orthopedics. 1998 Oct; 21(10):1123-8.
            
            
                Score: 0.144
            
         
        
        - 
            Monitoring low-dose warfarin therapy by a central laboratory and implications for clinical trials and patient care. The Coumadin Aspirin Reinfarction (CARS) Pilot Study Group. Am J Cardiol. 1996 Nov 01; 78(9):1074-6.
            
            
                Score: 0.126
            
         
        
        - 
            Effect of treatment with low-dose warfarin-aspirin on activated factor VII. Blood. 1995 Jun 01; 85(11):3034-9.
            
            
                Score: 0.114
            
         
        
        - 
            Warfarin-induced skin necrosis. Semin Thromb Hemost. 1990 Oct; 16(4):293-8.
            
            
                Score: 0.082
            
         
        
        - 
            Acquired deficiencies of protein S. Protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulation. J Clin Invest. 1988 May; 81(5):1445-54.
            
            
                Score: 0.070
            
         
        
        - 
            Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty. J Bone Joint Surg Am. 2005 Oct; 87(10):2169-77.
            
            
                Score: 0.058
            
         
        
        - 
            Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement. N Engl J Med. 2003 Oct 30; 349(18):1703-12.
            
            
                Score: 0.051
            
         
        
        - 
            Treatment and management of acute venous thromboembolic disease. Thromb Res. 2003; 111(1-2):3-8.
            
            
                Score: 0.048
            
         
        
        - 
            Safety and anticoagulation effect of a low-dose combination of warfarin and aspirin in clinically stable coronary artery disease. Coumadin Aspirin Reinfarction (CARS) Pilot Study Group. Am J Cardiol. 1994 Oct 01; 74(7):657-61.
            
            
                Score: 0.027
            
         
        
        - 
            Recent advances in understanding clotting and evaluating patients with recurrent thrombosis. Am J Obstet Gynecol. 1992 Oct; 167(4 Pt 2):1184-91.
            
            
                Score: 0.024
            
         
        
        - 
            Anticoagulation proteins C and S. Adv Exp Med Biol. 1987; 214:47-54.
            
            
                Score: 0.016
            
         
        
        - 
            Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease states. J Clin Invest. 1986 Feb; 77(2):416-25.
            
            
                Score: 0.015
            
         
        
        - 
            Determination of functional levels of protein C, an antithrombotic protein, using thrombin-thrombomodulin complex. Blood. 1984 Jan; 63(1):15-21.
            
            
                Score: 0.013